Related Experiment Videos
Decreased mRNA levels coding for poly(ADP-ribose) polymerase in lymphocytes of patients with SLE
J S Lee1, B L Haug, J T Sibley
1Department of Biochemistry, University of Saskatchewan, Saskatoon, Canada.
Abstract:
Poly(ADP-ribose) metabolism is altered in patients with SLE. In order to localize the defect, the levels of poly(ADP-ribose) polymerase-specific mRNA were measured from dot blots of total RNA from peripheral blood lymphocytes. In this preliminary study, eleven patients with SLE and two with antiphospholipid syndrome were compared to three controls. It was found that the mean levels of specific mRNA were ten fold lower in the PBL from SLE patients compared to controls and no overlap of values was seen between the two groups. No such decrease was seen in the PBL from the patients with antiphospholipid syndrome. It is concluded that the defect in poly(ADP-ribose) polymerase metabolism that is seen in SLE patients occurs at the level of transcription or mRNA turnover.
Insights
Patients with Systemic Lupus Erythematosus (SLE) show a significant ten-fold decrease in poly(ADP-ribose) polymerase mRNA levels in peripheral blood lymphocytes. This suggests a defect at the transcription or mRNA turnover level in SLE.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Poly(ADP-ribose) metabolism is known to be altered in patients diagnosed with Systemic Lupus Erythematosus (SLE).
- Localizing the specific defect in this metabolic pathway is crucial for understanding SLE pathogenesis.
Purpose of the Study:
- To investigate and localize the defect in poly(ADP-ribose) metabolism within SLE patients.
- To compare poly(ADP-ribose) polymerase mRNA levels in patients with SLE and antiphospholipid syndrome against healthy controls.
Main Methods:
- Measurement of poly(ADP-ribose) polymerase-specific mRNA levels.
- Utilized dot blot analysis of total RNA extracted from peripheral blood lymphocytes (PBL).
- Compared eleven SLE patients, two antiphospholipid syndrome patients, and three control subjects.
Main Results:
- Peripheral blood lymphocytes from SLE patients exhibited mean mRNA levels ten-fold lower than controls.
- A clear distinction in mRNA levels was observed, with no overlap between SLE patients and controls.
- No significant decrease in mRNA levels was detected in patients with antiphospholipid syndrome.
Conclusions:
- The observed defect in poly(ADP-ribose) polymerase metabolism in SLE patients likely originates at the level of gene transcription or mRNA turnover.
- These findings highlight a specific molecular abnormality in SLE, distinct from antiphospholipid syndrome.
- Further research into transcriptional regulation and mRNA stability in SLE is warranted.